Mindfulness Based Stress Reduction Program for Autistic Disorder

Phase-Based Progress Estimates
Autistic Disorder+2 More
Mindfulness Based Stress Reduction - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial is studying how well two different stress-reduction classes help adults with ASD manage symptoms by looking at changes in brain functioning.

Eligible Conditions
  • Autistic Disorder
  • Autism Spectrum Disorders
  • Autism Spectrum Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: Post-intervention (~10 weeks)

Baseline; Pre-intervention
Beck Depression Inventory - II
Baseline; Pre-intervention and Post-intervention
World Health Organization Quality of Life
Post-intervention (~10 weeks)
Beck Depression Inventory - 2
Blood-oxygen-level dependent (BOLD) response in brain regions activated during a self-reflection fMRI task
Blood-oxygen-level dependent (BOLD) response in regions activated during an emotion-regulation fMRI task
Event-Related Potentials (ERP) measured during regulation of affective responses
State-Trait Anxiety Inventory

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Mindfulness Based Stress Reduction Program
1 of 2
Relaxation Group
1 of 2
Active Control

108 Total Participants · 2 Treatment Groups

Primary Treatment: Mindfulness Based Stress Reduction Program · No Placebo Group · N/A

Mindfulness Based Stress Reduction Program
ActiveComparator Group · 1 Intervention: Mindfulness Based Stress Reduction · Intervention Types: Behavioral
Relaxation Group
ActiveComparator Group · 1 Intervention: Relaxation Group · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: post-intervention (~10 weeks)

Who is running the clinical trial?

Banner Alzheimer's InstituteOTHER
6 Previous Clinical Trials
2,396 Total Patients Enrolled
Arizona State UniversityLead Sponsor
238 Previous Clinical Trials
89,018 Total Patients Enrolled
11 Trials studying Autistic Disorder
1,587 Patients Enrolled for Autistic Disorder
Southwest Autism Research and Resource Center (SARRC)UNKNOWN
1 Previous Clinical Trials
12,000 Total Patients Enrolled
Brittany B Braden, PhDPrincipal InvestigatorAssistant Professor; Autism and Brain Aging Laboratory Director

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 30th, 2021

Last Reviewed: October 31st, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.